GBA2 - glucosylceramidase beta 2 Gene
Also Known as AD035; SPG46; NLGase
Species: Homo sapiens
About GBA2
This gene has 8 transcripts (splice variants), 198 orthologues and is associated with 4 phenotypes. Ubiquitous expression in small intestine (RPKM 30.3), duodenum (RPKM 27.9) and 25 other tissues.
Summary
This gene encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Studies to determine subcellular localization of this protein in the liver indicated that the enzyme was mainly enriched in the microsomal fraction where it appeared to be confined to the endoplasmic reticulum. This putative transmembrane protein is thought to play a role in carbohydrate transport and metabolism. [provided by RefSeq, Jul 2008]
GBA2 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001330660.2 | NP_001317589.1 | non-lysosomal glucosylceramidase isoform 2 |
| NM_020944.3 | NP_065995.1 | non-lysosomal glucosylceramidase isoform 1 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables beta-glucosidase activity |
IDA
IDA: Inferred from direct assay
|
11489889 | GOA |
| enables glucosylceramidase activity |
IDA
IDA: Inferred from direct assay
|
17080196 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in bile acid metabolic process |
IDA
IDA: Inferred from direct assay
|
17105727 | GOA |
| involved in central nervous system neuron development |
IMP
IMP: Inferred from mutant phenotype
|
23332916 | GOA |
| involved in glucosylceramide catabolic process |
IDA
IDA: Inferred from direct assay
|
17080196 | GOA |
| involved in glucosylceramide catabolic process |
IMP
IMP: Inferred from mutant phenotype
|
30308956 | GOA |
| involved in glycoside catabolic process |
IDA
IDA: Inferred from direct assay
|
17105727 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in membrane |
IDA
IDA: Inferred from direct assay
|
17105727 | GOA |
GBA2 Protein Structure
Glyco_hydr_116N: beta-glucosidase 2, glycosyl-hydrolase family 116 N-term (151 - 455)
DUF608: Glycosyl-hydrolase family 116, catalytic region (521 - 887)
- 0
- 200
- 400
- 600
- 800
- 927 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
non-lysosomal glucosylceramidase |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Spastic Paraplegia 46, Autosomal Recessive |
|
|
| Autosomal Recessive Cerebellar Ataxia With Late-Onset Spasticity |
|
|
| Hereditary Spastic Paraplegia |
|
|
| Paraplegia |
|
|
| Spermatogenic Failure 9 |
|
|
| Gaucher Disease, Type I |
|
|
| Parkinson Disease 4, Autosomal Dominant |
|
|
| Spastic Paraplegia 77, Autosomal Recessive |
|
|
| Spinocerebellar Ataxia, Autosomal Recessive 21 |
|
|
| Sandhoff Disease |
|
|
| Spastic Paraplegia 26, Autosomal Recessive |
|
|
| Spastic Paraplegia 54, Autosomal Recessive |
|
|
| Sphingolipidosis |
|
|
| Spastic Paraplegia 43, Autosomal Recessive |
|
|
| Progressive Myoclonus Epilepsy 4 |
|
|
| Spastic Paraplegia 48, Autosomal Recessive |
|
|
| Gm2 Gangliosidosis |
|
|
| Gaucher'S Disease |
|
|
| C Syndrome |
|
|
| Spinocerebellar Ataxia, Autosomal Recessive 24 |
|
|
| Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex 1 |
|
|
| Spasticity |
|
|
| Gm1-Gangliosidosis, Type Iii |
|
|
| Spastic Paraplegia 14, Autosomal Recessive |
|
|
| Gangliosidosis |
|
|
| Gm1 Gangliosidosis |
|
|
| Krabbe Disease |
|
|
| Spastic Ataxia |
|
|
| Dystonia |
|
|
| Tay-Sachs Disease |
|
|
| Niemann-Pick Disease |
|
|
| Parkinson Disease, Late-Onset |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Felis catus | GBA2 | VGNC | VGNC:62482 |
| Rattus norvegicus | GBA2 | RGD | RGD:1305598 |
| Mus musculus | GBA2 | MGD | MGI:2654325 |
| Macaca mulatta | GBA2 | VGNC | VGNC:72741 |
| Canis familiaris | GBA2 | VGNC | VGNC:41131 |
| Bos taurus | GBA2 | VGNC | VGNC:29275 |
| Others | GBA2 | NCBI |